Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving
- PMID: 15661634
- DOI: 10.1016/j.coph.2004.08.013
Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving
Abstract
Pharmacological agents have shown limited efficacy and consistency in the treatment of drug addiction. Hence, the development of new medications with improved long-term efficacy and reduced side effects should be given a high priority given the costs to society associated with drug abuse and drug-related pathologies. Neurochemical systems can be significantly altered by repeated exposure to drugs of abuse. These long-term molecular and neurochemical changes might, in turn, explain the core features of addiction--the compulsive seeking and taking of the drug--as well as the risk of relapse.
Similar articles
-
Pharmacotherapy of addictions.Nat Rev Drug Discov. 2002 Sep;1(9):710-26. doi: 10.1038/nrd897. Nat Rev Drug Discov. 2002. PMID: 12209151 Review.
-
Vivitrex (Alkermes/Cephalon).Curr Opin Investig Drugs. 2006 Jan;7(1):81-8. Curr Opin Investig Drugs. 2006. PMID: 16425675 Review.
-
Pharmacotherapies for adolescent substance use disorders.Child Adolesc Psychiatr Clin N Am. 2010 Jul;19(3):591-608. doi: 10.1016/j.chc.2010.03.010. Child Adolesc Psychiatr Clin N Am. 2010. PMID: 20682223 Review.
-
[Limited role of naltrexone in the treatment of opiate addiction].Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6. Ned Tijdschr Geneeskd. 2001. PMID: 11503313 Review. Dutch.
-
Clinical uses of naltrexone: a review of the evidence.Exp Clin Psychopharmacol. 2002 Aug;10(3):213-27. doi: 10.1037//1064-1297.10.3.213. Exp Clin Psychopharmacol. 2002. PMID: 12233982 Review.
Cited by
-
Inhibition of the development of morphine tolerance by a potent dual mu-delta-opioid antagonist, H-Dmt-Tic-Lys-NH-CH2-Ph.Pharmacol Biochem Behav. 2008 Oct;90(4):651-7. doi: 10.1016/j.pbb.2008.05.008. Pharmacol Biochem Behav. 2008. PMID: 18571706 Free PMC article.
-
Anti-relapse medications: preclinical models for drug addiction treatment.Pharmacol Ther. 2009 Nov;124(2):235-47. doi: 10.1016/j.pharmthera.2009.06.014. Epub 2009 Aug 13. Pharmacol Ther. 2009. PMID: 19683019 Free PMC article. Review.
-
Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal.Br J Pharmacol. 2011 Oct;164(4):1335-56. doi: 10.1111/j.1476-5381.2011.01406.x. Br J Pharmacol. 2011. PMID: 21470204 Free PMC article. Review.
-
Preclinical assessment of CNS drug action using eye movements in mice.J Clin Invest. 2011 Sep;121(9):3528-41. doi: 10.1172/JCI45557. Epub 2011 Aug 8. J Clin Invest. 2011. PMID: 21821912 Free PMC article.
-
Activation of group II metabotropic glutamate receptors inhibits the discriminative stimulus effects of alcohol via selective activity within the amygdala.Neuropsychopharmacology. 2011 Oct;36(11):2328-38. doi: 10.1038/npp.2011.121. Epub 2011 Jul 6. Neuropsychopharmacology. 2011. PMID: 21734651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical